GLRX and Alzheimer disease: Glutaredoxin And Cysteine Rich Domain Containing 1 (GRXCR1) that may function in cell survival was observed in the plasma of AD patients and Glutaredoxin was released to the cerebrospinal fluid in the early stages of AD [101].